Zepp Health ROE 2017-2025 | ZEPP
Current and historical return on equity (ROE) values for Zepp Health (ZEPP) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Zepp Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.08B | $0.23B | -28.83% |
| 2024-12-31 | $-0.08B | $0.25B | -24.78% |
| 2024-09-30 | $-0.04B | $0.32B | -12.06% |
| 2024-06-30 | $-0.03B | $0.32B | -7.95% |
| 2024-03-31 | $-0.03B | $0.34B | -7.52% |
| 2023-12-31 | $-0.03B | $0.35B | -8.73% |
| 2023-09-30 | $-0.04B | $0.35B | -10.71% |
| 2023-06-30 | $-0.04B | $0.35B | -10.94% |
| 2023-03-31 | $-0.05B | $0.37B | -12.01% |
| 2022-12-31 | $-0.04B | $0.39B | -10.01% |
| 2022-09-30 | $-0.02B | $0.39B | -5.65% |
| 2022-06-30 | $-0.01B | $0.41B | -1.83% |
| 2022-03-31 | $0.00B | $0.44B | 0.46% |
| 2021-09-30 | $0.04B | $0.45B | 8.12% |
| 2021-06-30 | $0.04B | $0.44B | 9.38% |
| 2021-03-31 | $0.03B | $0.42B | 6.82% |
| 2020-12-31 | $0.04B | $0.42B | 9.43% |
| 2020-09-30 | $0.05B | $0.39B | 12.81% |
| 2020-06-30 | $0.06B | $0.36B | 18.00% |
| 2020-03-31 | $0.07B | $0.36B | 22.11% |
| 2019-12-31 | $0.08B | $0.36B | 25.99% |
| 2019-09-30 | $0.04B | $0.32B | 12.69% |
| 2019-06-30 | $0.03B | $0.30B | 9.20% |
| 2019-03-31 | $0.03B | $0.28B | 9.87% |
| 2018-12-31 | $0.02B | $0.26B | 6.75% |
| 2018-09-30 | $0.04B | $0.24B | 23.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.037B | $0.183B |
| Zepp Health Corp. developed a platform of proprietary technology including AI chips, biometric sensors and health data algorithms, which drive a broadening line of smart health products for consumers and analytics services for insurers, healthcare providers, employers, drug and treatment companies. Zepp Health Corp., formerly known as Huami Corporation, is based in CUPERTINO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.674B | 58.11 |
| Tempus AI (TEM) | United States | $11.334B | 0.00 |
| Doximity (DOCS) | United States | $11.302B | 52.32 |
| Hims & Hers Health (HIMS) | United States | $9.269B | 96.30 |
| IRhythm Technologies (IRTC) | United States | $4.836B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.893B | 60.83 |
| Hinge Health (HNGE) | United States | $3.474B | 0.00 |
| Privia Health (PRVA) | United States | $2.652B | 181.25 |
| Enovis (ENOV) | United States | $1.835B | 10.23 |
| Phreesia (PHR) | United States | $1.643B | 0.00 |
| Schrodinger (SDGR) | United States | $1.509B | 0.00 |
| 10x Genomics (TXG) | United States | $1.436B | 0.00 |
| Azenta (AZTA) | United States | $1.397B | 64.92 |
| Clover Health Investments (CLOV) | United States | $1.394B | 0.00 |
| Omnicell (OMCL) | United States | $1.346B | 23.75 |
| Evolent Health (EVH) | United States | $1.257B | 107.10 |
| Claritev (CTEV) | United States | $0.687B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.596B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.487B | 0.00 |
| Standard BioTools (LAB) | United States | $0.475B | 0.00 |
| Talkspace (TALK) | United States | $0.452B | 135.00 |
| Outset Medical (OM) | United States | $0.347B | 0.00 |
| TruBridge (TBRG) | United States | $0.343B | 762.00 |
| Nyxoah SA (NYXH) | Belgium | $0.265B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.262B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.211B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.157B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| CareCloud (CCLD) | United States | $0.107B | 4.06 |
| Pulmonx (LUNG) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.105B | 0.00 |
| 111 (YI) | China | $0.067B | 0.00 |
| HeartBeam (BEAT) | United States | $0.048B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |